SCHEMBL3397625

SCHEMBL3397625

CCC(CC)(CO)c1ccc(Br)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.35
ESR2 Q92731 2/20 0.35
CYP2A6 P11509 1/20 0.35
HDAC3 O15379 3/20 0.34
HDAC1 Q13547 3/20 0.34
HDAC2 Q92769 3/20 0.34
ALDH1A1 P00352 2/20 0.33
POLB P06746 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
OGG1 O15527 1/20 0.33
ALOX15 P16050 1/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
NCOR2 Q9Y618 1/20 0.33
GAA P10253 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25278922 0.89 CYP2A6 (0.44) ESR1ESR2CYP2A6HDAC3HDAC1
SCHEMBL2672720 0.86 CYP2A6 (0.42) CYP2A6ALDH1A1OGG1ALOX15TSHR
SCHEMBL915727 0.77 KCNN4 (0.41) ESR1ESR2ALDH1A1ALOX15TP53
SCHEMBL7875120 0.77 PDE2A (0.41) ESR1ESR2AR
SCHEMBL23893792 0.77 ALDH1A1 (0.41) ESR1ESR2CYP2A6HDAC3HDAC1
SCHEMBL8507545 0.75 CA1 (0.44) ALDH1A1ALOX15TSHRCA1CA2
SCHEMBL7873455 0.74 KIF11 (0.46) CYP2A6ALDH1A1CA2CA9
SCHEMBL2656106 0.74 SMN1; SMN2 (0.36) CYP2A6ALDH1A1OGG1TSHRSMN1; SMN2
SCHEMBL3045994 0.73 CNR1 (0.42) ESR1ESR2CYP2A6ALDH1A1POLB
SCHEMBL1684429 0.73 CYP2A6 (0.38) ESR1ESR2CYP2A6HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100204119-A1 4-AMINO-5-OXO-7,8-DIHYDROPYRIMIDO[5,4-F][1,4]OXAZEPIN-6(5H)-YL PHENYL DERIVATIVES PFIZER INC 2010-08-12 US disclosed
WO-2010086820-A1 4-AMINO-5-OXO-7, 8-DIHYDROPYRIMIDO [5,4-F] [1,4] OXAZEPIN-6 (5H) -YL) PHENYL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF PFIZER INC. (US) 2010-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204119-A1 4-AMINO-5-OXO-7,8-DIHYDROPYRIMIDO[5,4-F][1,4]OXAZEPIN-6(5H)-YL PHENYL DERIVATIVES DGAT1, DGAT2, MOGAT2 ESR1 3118/4885ESR2 2053/4885CYP2A6 305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.